Loading clinical trials...

Dose Response and Receptor Selectivity of Beta-blocker Effects on Bone Metabolism | Clinical Trials | Clareo Health

COMPLETEDEARLY Phase 1NCT02467400

Dose Response and Receptor Selectivity of Beta-blocker Effects on Bone Metabolism

This study is designed to answer the question as to whether the sympathetic nervous system is an important determinant of bone metabolism in humans.

Lead sponsor: Mayo Clinic•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDNA

Bone Mineral Density and Bone Metabolism in Older Women

NCT06529172 · Osteoporosis, Age-Related

COMPLETEDPhase 3

Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)

NCT03512262 · Osteoporosis, Osteoporosis, Age-Related, and more

COMPLETED

Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis

NCT02732210 · Osteoporosis, Age-Related

COMPLETEDPhase 3

Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption

NCT03710889 · Osteoporosis, Postmenopausal, Osteoporosis, and more

COMPLETEDNA

Tart Cherry Supplementation and Women's Bone Health Study

NCT04167150 · Osteoporosis, Postmenopausal, Osteoporosis, Age-Related

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 6, 2019Terms

Trial snapshot

StatusCOMPLETED

PhaseEARLY_PHASE1

Enrollment165

Start dateJul 2015

Last updatedFeb 6, 2019

Condition

Osteoporosis, Age-Related

Locations shown

Mayo Clinic in Rochester

Rochester, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 6, 2019Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions